| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |